pharmacie et médicaments – Remise sur les médicaments génériques

This written question concerns rebates on generic medicines within the pharmaceutical sector. It seeks clarification on the current policies and potential impacts of these rebates on the availability and pricing of generic drugs. The question is directed towards understanding the implications for patients, healthcare providers, and the pharmaceutical industry, particularly regarding cost-effectiveness and access to essential medicines.